What is ReGen-GF used for?

ReGen-GF is indicated for Chronic wounds, Diabetic foot ulcers.

ReGen-GF is developed by Austin Institute for Clinical Research.

What development phase is ReGen-GF in?

ReGen-GF is FDA-approved (marketed).

What are the side effects of ReGen-GF?

Common side effects include Injection site reactions, Systemic reactions, Wound infection.

Last reviewed 2026-04-23 · How we verify

ReGen-GF

Austin Institute for Clinical Research · FDA-approved active Small molecule

ReGen-GF is a recombinant human growth factor that promotes tissue regeneration and repair.

ReGen-GF is a recombinant human growth factor that promotes tissue regeneration and repair. Used for Chronic wounds, Diabetic foot ulcers.

At a glance

Generic name	ReGen-GF
Sponsor	Austin Institute for Clinical Research
Drug class	growth factor
Target	GF
Modality	Small molecule
Therapeutic area	Wound healing
Phase	FDA-approved

Mechanism of action

ReGen-GF works by stimulating the proliferation and differentiation of cells involved in tissue repair, leading to improved wound healing and tissue regeneration. This is achieved through the activation of various signaling pathways that promote cell growth and survival.

Approved indications

Chronic wounds, Diabetic foot ulcers

Common side effects

Injection site reactions
Systemic reactions
Wound infection

Key clinical trials

Trial Assessing the Impact on Facial Skin Quality, Hydration, and Skin Barrier of Three (3) Hydrafacial Treatments in Adults of All Skin Types. (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results